Cargando…
Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation
Autores principales: | Mulhern, Ciara M., Hong, Ying, Omoyinmi, Ebun, Jacques, Thomas S., D'Arco, Felice, Hemingway, Cheryl, Brogan, Paul A., Eleftheriou, Despina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721833/ https://www.ncbi.nlm.nih.gov/pubmed/31175876 http://dx.doi.org/10.1016/j.jaci.2019.05.026 |
Ejemplares similares
-
Autoinflammation due to homozygous S208 MEFV mutation
por: Hong, Ying, et al.
Publicado: (2019) -
Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2019) -
Gene hunting in autoinflammation
por: Standing, Ariane, et al.
Publicado: (2013) -
Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in C3
por: Omoyinmi, Ebun, et al.
Publicado: (2018) -
TRAP1 chaperone protein mutations and autoinflammation
por: Standing, Ariane SI, et al.
Publicado: (2019)